Title : Osteogenesis imperfecta: Genetic foundations, clinical types, and modern rehabilitation approaches
Abstract:
Background: Osteogenesis imperfecta is a rare genetic disorder. The main cause of the condition is mutations in the COL1A1 and COL1A2 genes. As a result, bones fracture frequently and appear fragile and thin. Osteogenesis imperfecta is inherited in an autosomal dominant pattern. In some cases, OI can also occur due to a new mutation (de novo). Studying osteogenesis imperfecta is very important. Because OI is a rare disorder, understanding the disease is crucial for improving patient care, enhancing quality of life, and developing new treatment methods. Research plays an essential role in deeply understanding the disorder and evaluating how current treatments benefit patients.
Objective: The article provides in-depth information about the disorder. It presents a detailed scientific analysis of the symptoms, types, modern treatment methods, the Sofield–Miller surgery, intramedullary rods, recent research and future perspectives, and postoperative recovery.
Methods: Scientific literature, as well as my personal experience and observations, were used in writing this article.
Results & Key Findings: According to my personal observations, after receiving zoledronic acid, my bone strength improved, the healing process after surgery accelerated, and pain decreased. After the Sofield–Miller surgery, deformities in my legs were corrected. There are notable differences between clinical presentations of OI. Based on my observation, bone regeneration was recorded within 4 months.
Intramedullary rod placement increases bone stability in children with OI.
Conclusion: This article provides an in-depth analysis of the clinical features, diagnostic approaches, and treatment strategies of OI. The personal clinical case demonstrates that individual experience can offer valuable practical insight into understanding OI and analyzing the processes occurring in patients.
Keywords: genetic disorder, osteogenesis imperfecta, intramedullary rod, pediatric orthopedics, zoledronic acid.
